Chris Cline
Vermogen: 6 M $ op 31-05-2026
Vermogen: 6 M $ op 31-05-2026
Chris Cline currently works at National Investor Relations Institute, as Member and Travere Therapeutics, Inc., as Chief Financial Officer from 2022.
Mr. Cline also formerly worked at Elan Corp.
Plc, as Member from 2012 to 2014 and Phase Forward, Inc., as Head-Financial Planning.
Mr. Cline received his undergraduate degree from Williams College of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-05-2026 | 118.658 ( 0,13% ) | 6 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Financieel Directeur/CFO | 31-08-2022 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | 01-02-2014 |
Phase Forward, Inc.
Phase Forward, Inc. Packaged SoftwareTechnology Services Develops e-process software solutions for accelerating global pharmaceutical development | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Phase Forward, Inc.
Phase Forward, Inc. Packaged SoftwareTechnology Services Develops e-process software solutions for accelerating global pharmaceutical development | Technology Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Williams College of Business
Williams College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau